Moore Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $19.3M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $20.6M | Sell |
|
|||||
|
2024
Q1 | $22.7M | Buy |
|
|||||
|
2023
Q4 | $20.2M | Buy |
|
|||||
|
2023
Q3 | $17.3M | Buy |
|
|||||
|
2023
Q2 | $13.9M | Buy |
|
|||||
|
2023
Q1 | $2.92M | Sell |
|
|||||
|
2022
Q4 | $13.5M | Buy |
|
|||||
|
2022
Q3 | $4.58M | Sell |
|
|||||
|
2022
Q2 | $6.18M | Buy |
|
|||||
|
2022
Q1 | $4.42M | Sell |
|
|||||
|
2021
Q4 | $15.2M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $12.8M | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $3.43M | Sell |
|
|||||
|
2014
Q4 | $5.07M | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $4.51M | Buy |
|